Fabrication and characterization of the active ingredient of nano drug thalidomide by asymmetric synthesis method

In this study, the active ingredient of nano drug thalidomide was produced using asymmetric synthesis method. Asymmetric synthesis is one of the common methods in the field of nano drug synthesis. The active ingredient of thalidomide nano drug produced was investigated via different analyzes. To prove the synthesis of the produced nano drug, first Energy-dispersive X-ray spectroscopy (EDX) analysis was used. Then, the synthesis of nano drug thalidomide was studied using hydrogen nucleus magnetic resonance spectroscopy (HNMR) and Fourier transform infrared spectroscopy (FTIR). In the next step, a transmission electron microscope (TEM) was used to examine the nanometer structure of the synthesized drug. The nanometer dimensions of the synthesized drug were confirmed using the transmission electron microscope. Finally, in order to evaluate the improvement of the synthesized nano drug with normal drug, the release time of the drug in human stomach conditions was investigated and the release rate of thalidomide over time was evaluated using ultraviolet-visible absorption spectrometer (UV-Vis).